Summary
The U.S. government, under Health Secretary Robert F. Kennedy Jr., is ending 22 federal contracts for mRNA vaccine development. The World Health Organization (WHO) states this decision is a setback for vaccine technology. The contracts' termination affects various companies and involves projects totaling nearly $500 million.
Key Facts
- The U.S. is terminating 22 contracts related to mRNA vaccine development.
- This decision impacts projects worth about $500 million.
- Terminology: mRNA vaccines deliver genetic instructions to cells, unlike traditional vaccines.
- The WHO has expressed concern over the end of these contracts, describing the move as a significant setback.
- Robert F. Kennedy Jr., known for skeptical views on vaccines, leads the U.S. Health Department making these changes.
- Affected companies include Moderna, Pfizer, Sanofi Pasteur, CSL Seqirus, and others.
- The U.S. plans to redirect funds to other vaccine platforms that remain effective as viruses mutate.
- The decision follows a review of mRNA vaccine investments initiated during the COVID-19 emergency.
